Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anorexia Nervosa

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Children With Attention-Deficit/Hyperactivity Disorder Are at Increased Risk for Slowed Growth and Short Stature in Early Childhood.

Clinical pediatrics·2020

Same author

Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT): a protocol for a randomised factorial, double-blind, placebo-controlled trial of azithromycin, nitazoxanide and nicotinamide.

BMJ open·2018

Same author

Reply.

The Journal of pediatrics·2016

Same author

Treatment of cachexia: melanocortin and ghrelin interventions.

Vitamins and hormones·2013

Same author

Partial normalization of pubertal timing in female mice with DSS colitis treated with anti-TNF-α antibody.

Journal of gastroenterology·2012

Same author

Update on melanocortin interventions for cachexia: progress toward clinical application.

Nutrition (Burbank, Los Angeles County, Calif.)·2009

Same journal

Why Next-generation mechanistic models Will transform drug discovery: integrating efficacy and safety.

Expert opinion on drug discovery·2026

Same journal

Toward a nuanced framework for the medical development of ibogaine and its analogues and derivatives: implications for psychopharmacology.

Expert opinion on drug discovery·2026

Same journal

From mitochondrial signal to discovery decision: a reserve-demand framework for translational risk assessment.

Expert opinion on drug discovery·2026

Same journal

Advances in 3D cell culture models for alzheimer's disease drug discovery.

Expert opinion on drug discovery·2026

Same journal

Are patient-derived models of amyotrophic lateral sclerosis a game changer for novel drug discovery?

Expert opinion on drug discovery·2026

Same journal

Unfolding prion misfolding and the challenge of identifying effective therapeutics: is there hope on the horizon?

Expert opinion on drug discovery·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Animal models of anorexia and cachexia.

Mark Daniel Deboer¹

¹Division of Pediatric Endocrinology, University of Virginia.

Expert Opinion on Drug Discovery

|February 18, 2010

Summary

This summary is machine-generated.

Animal models are crucial for developing new cachexia treatments. This review details cancer, heart, and kidney disease models to test therapies before human trials, aiding drug development.

More Related Videos

Assessing Activity-based Anorexia in Mice

Assessing Activity-based Anorexia in Mice

Published on: May 14, 2018

Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa

Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa

Published on: October 22, 2015

Related Experiment Videos

Last Updated: Jun 16, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Assessing Activity-based Anorexia in Mice

Assessing Activity-based Anorexia in Mice

Published on: May 14, 2018

Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa

Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa

Published on: October 22, 2015

Area of Science:

Biomedical research
Translational medicine
Disease modeling

Background:

Cachexia is a severe wasting syndrome impacting cancer, chronic kidney disease, and heart failure patients.
Current treatments for cachexia are limited, highlighting the need for novel therapeutic compounds.
Animal models effectively mimic human cachexia, serving as essential tools for preclinical therapy evaluation.

Purpose of the Study:

To review animal models of cachexia associated with cancer, chronic heart failure, and chronic kidney disease.
To describe the characteristics, application, and outcome measures used in these models.
To emphasize the role of animal models in advancing cachexia treatment research.

Main Methods:

Literature review of existing animal models for cachexia.
Analysis of model features, implementation strategies, and common endpoints.
Focus on models relevant to cancer, chronic heart failure, and chronic kidney disease.

Main Results:

Animal models successfully replicate key features of human cachexia.
These models provide a platform for assessing the efficacy of potential anti-cachexia therapies.
Established outcome measures guide the evaluation of treatment effectiveness in preclinical settings.

Conclusions:

Animal models are indispensable for evaluating the efficacy and safety of cachexia treatments before human trials.
Future research should utilize animal models to assess treatment durability and impact on disease prognosis.
Continued development and refinement of animal models are vital for addressing the clinical need for effective cachexia therapies.